electroCore, Inc. financial data

Symbol
ECOR on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
200 Forge Way, Suite 205, Rockaway, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Former names
ElectroCore, LLC (to 6/20/2018)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 195 % -30.5%
Quick Ratio 30.7 % -8.87%
Debt-to-equity 110 % +125%
Return On Equity -94.1 % -27.9%
Return On Assets -78.5 % +22.6%
Operating Margin -68.3 % +67.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.45M shares +7.72%
Common Stock, Shares, Outstanding 6.45M shares +35.7%
Entity Public Float 22.4M USD -32.5%
Common Stock, Value, Issued 6K USD +20%
Weighted Average Number of Shares Outstanding, Basic 7.05M shares +48.3%
Weighted Average Number of Shares Outstanding, Diluted 7.05M shares +48.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 21.3M USD +95.8%
Research and Development Expense 3.39M USD -45.4%
Operating Income (Loss) -14.5M USD +35.9%
Nonoperating Income (Expense) 202K USD -54.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.3M USD +35.5%
Income Tax Expense (Benefit) -122K USD +42.2%
Net Income (Loss) Attributable to Parent -14.2M USD +35.4%
Earnings Per Share, Basic -2.06 USD/shares +54.8%
Earnings Per Share, Diluted -2.06 USD/shares +54.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.3M USD +22%
Marketable Securities, Current 3.93M USD
Cash, Cash Equivalents, and Short-term Investments 14.2M USD
Accounts Receivable, after Allowance for Credit Loss, Current 538K USD +126%
Inventory, Net 2.58M USD +9%
Assets, Current 18M USD +57.5%
Property, Plant and Equipment, Net 181K USD +58.8%
Operating Lease, Right-of-Use Asset 3.78M USD +607%
Other Assets, Noncurrent 440K USD -46.3%
Assets 22.4M USD +57.2%
Accounts Payable, Current 1.46M USD -36.3%
Accrued Liabilities, Current 5.45M USD +29.5%
Liabilities, Current 7.25M USD +10.3%
Operating Lease, Liability, Noncurrent 3.63M USD +523%
Liabilities 10.9M USD +52%
Accumulated Other Comprehensive Income (Loss), Net of Tax 45K USD
Retained Earnings (Accumulated Deficit) -171M USD -9.05%
Stockholders' Equity Attributable to Parent 11.5M USD +62.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.8M USD -62.7%
Liabilities and Equity 22.4M USD +57.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.56M USD +56.3%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 6.45M shares +35.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.48M USD +57.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.6M USD +21.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD +150%
Deferred Tax Assets, Valuation Allowance 40.6M USD +9.5%
Deferred Tax Assets, Gross 40.8M USD +9.36%
Operating Lease, Liability 3.97M USD +498%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.1M USD +47.2%
Lessee, Operating Lease, Liability, to be Paid 10.7M USD +1016%
Operating Lease, Liability, Current 342K USD +322%
Lessee, Operating Lease, Liability, to be Paid, Year Two 516K USD +202%
Lessee, Operating Lease, Liability, to be Paid, Year One 369K USD +120%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.69M USD +2198%
Lessee, Operating Lease, Liability, to be Paid, Year Three 603K USD +275%
Deferred Tax Assets, Operating Loss Carryforwards 33.6M USD +12.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 627K USD +299%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 206K USD +68.9%
Deferred Tax Assets, Net of Valuation Allowance 285K USD -6.86%
Share-based Payment Arrangement, Expense 1.9M USD -0.47%
Interest Expense 2.25K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%